Biden Admin’s Last Part D Rule Also Has Generic Drug Exclusion Comments, Prescription Payment Plan Tweaks

 
• By Leslie Small
  
More changes are expected to the M3P plan due to its operational complexity. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Medicare

More from Market Access